Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2007 2
2008 2
2010 3
2011 4
2012 2
2013 1
2014 5
2015 5
2016 7
2017 6
2018 5
2019 2
2020 2
2022 2
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation.
Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, Hempel S, Akl EA, Chang C, McGowan J, Stewart L, Hartling L, Aldcroft A, Wilson MG, Garritty C, Lewin S, Godfrey CM, Macdonald MT, Langlois EV, Soares-Weiser K, Moriarty J, Clifford T, Tunçalp Ö, Straus SE. Tricco AC, et al. Among authors: weeks l. Ann Intern Med. 2018 Oct 2;169(7):467-473. doi: 10.7326/M18-0850. Epub 2018 Sep 4. Ann Intern Med. 2018. PMID: 30178033 Free article.
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials.
Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, Savovic J, Schulz KF, Weeks L, Sterne JA; Cochrane Bias Methods Group; Cochrane Statistical Methods Group. Higgins JP, et al. Among authors: weeks l. BMJ. 2011 Oct 18;343:d5928. doi: 10.1136/bmj.d5928. BMJ. 2011. PMID: 22008217 Free PMC article.
CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials.
Junqueira DR, Zorzela L, Golder S, Loke Y, Gagnier JJ, Julious SA, Li T, Mayo-Wilson E, Pham B, Phillips R, Santaguida P, Scherer RW, Gøtzsche PC, Moher D, Ioannidis JPA, Vohra S; CONSORT Harms Group. Junqueira DR, et al. BMJ. 2023 Apr 24;381:e073725. doi: 10.1136/bmj-2022-073725. BMJ. 2023. PMID: 37094878 Free article. Clinical Trial. No abstract available.
Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement.
McInnes MDF, Moher D, Thombs BD, McGrath TA, Bossuyt PM; and the PRISMA-DTA Group; Clifford T, Cohen JF, Deeks JJ, Gatsonis C, Hooft L, Hunt HA, Hyde CJ, Korevaar DA, Leeflang MMG, Macaskill P, Reitsma JB, Rodin R, Rutjes AWS, Salameh JP, Stevens A, Takwoingi Y, Tonelli M, Weeks L, Whiting P, Willis BH. McInnes MDF, et al. Among authors: weeks l. JAMA. 2018 Jan 23;319(4):388-396. doi: 10.1001/jama.2017.19163. JAMA. 2018. PMID: 29362800
Living systematic reviews: 4. Living guideline recommendations.
Akl EA, Meerpohl JJ, Elliott J, Kahale LA, Schünemann HJ; Living Systematic Review Network. Akl EA, et al. J Clin Epidemiol. 2017 Nov;91:47-53. doi: 10.1016/j.jclinepi.2017.08.009. Epub 2017 Sep 11. J Clin Epidemiol. 2017. PMID: 28911999 Free article. Review.
HPV Testing for Primary Cervical Cancer Screening: A Health Technology Assessment [Internet].
Chao YS, Clark M, Carson E, Weeks L, Moulton K, McFaul S, McLauchlin CM, Tsoi B, Majid U, Kandasamy S, Arora N, Vanstone M, Reid L, Krahn T, Kaluzny K, Farrah K, Ford C. Chao YS, et al. Among authors: weeks l. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Mar. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2019 Mar. PMID: 31246380 Free Books & Documents. Review.
Composite Resin Versus Amalgam for Dental Restorations: A Health Technology Assessment [Internet].
Khangura SD, Seal K, Esfandiari S, Quiñonez C, Mierzwinski-Urban M, Mulla SM, Laplante S, Tsoi B, Godfrey C, Weeks L, Helis E, Wells C, Pullman D, Basu N. Khangura SD, et al. Among authors: weeks l. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Mar. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2018 Mar. PMID: 30325626 Free Books & Documents. Review.
A scoping review establishes need for consensus guidance on reporting health equity in observational studies.
Wang X, Dewidar O, Rizvi A, Huang J, Desai P, Doyle R, Ghogomu E, Rader T, Nicholls SG, Antequera A, Krentel A, Shea B, Hardy BJ, Chamberlain C, Wiysonge CS, Feng C, Juando-Prats C, Lawson DO, Obuku EA, Kristjansson E, von Elm E, Wang H, Ellingwood H, Waddington HS, Ramke J, Jull JE, Hatcher-Roberts J, Tufte J, Little J, Mbuagbaw L, Weeks L, Niba LL, Cuervo LG, Wolfenden L, Kasonde M, Avey MT, Sharp MK, Mahande MJ, Nkangu M, Magwood O, Craig P, Tugwell P, Funnell S, Noorduyn SG, Kredo T, Horsley T, Young T, Pantoja T, Bhutta Z, Martel A, Welch VA. Wang X, et al. Among authors: weeks l. J Clin Epidemiol. 2023 Aug;160:126-140. doi: 10.1016/j.jclinepi.2023.06.009. Epub 2023 Jun 15. J Clin Epidemiol. 2023. PMID: 37330072 Free article. Review.
CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomized trials.
Junqueira DR, Zorzela L, Golder S, Loke Y, Gagnier JJ, Julious SA, Li T, Mayo-Wilson E, Pham B, Phillips R, Santaguida P, Scherer RW, Gøtzsche PC, Moher D, Ioannidis JPA, Vohra S; CONSORT Harms Group. Junqueira DR, et al. J Clin Epidemiol. 2023 Jun;158:149-165. doi: 10.1016/j.jclinepi.2023.04.005. Epub 2023 Apr 24. J Clin Epidemiol. 2023. PMID: 37100738 Free article.
52 results